Literature DB >> 28558091

Long-Acting Reversible Contraception for Adolescents: A Review.

Jenny K R Francis1, Melanie A Gold2.   

Abstract

Importance: Adolescents have higher rates of unintended pregnancies than any other age group. Contraceptive implants and intrauterine devices (IUDs) are long-acting reversible contraceptives (LARCs) that are known to be highly effective in preventing pregnancy. New devices have recently been approved for use in adolescents, yet pediatricians may be less familiar with how to counsel adolescents about implants and IUDs. Observations: LARC methods should be described in basic terms to adolescents, including hormone dose, method of insertion, and method of pregnancy prevention. Clinicians should appreciate the developmental stages of adolescents, discuss the most effective methods of contraception, and ensure confidentiality from their parents. Short-acting contraception methods (eg, oral contraceptives) can be used as a temporary bridge to provide coverage until a LARC method can be placed. The most common adverse effect of LARC is nuisance bleeding, which can be managed with short courses of oral contraceptives or nonsteroidal anti-inflammatory drugs. Conclusions and Relevance: LARC devices constitute first-line contraceptive methods for adolescents. All clinicians, including pediatricians, can counsel about LARC even before suggesting an oral contraceptive or another less effective contraceptive method. Effective, confidential communication with sensitive language to inform adolescents of the different types of LARC is necessary to normalize offering LARC as a contraceptive option and improve its uptake among adolescents. Special clinical populations can also be offered appropriate contraceptive options inclusive of LARC.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28558091     DOI: 10.1001/jamapediatrics.2017.0598

Source DB:  PubMed          Journal:  JAMA Pediatr        ISSN: 2168-6203            Impact factor:   16.193


  5 in total

Review 1.  Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine-device use.

Authors:  Karen Christelle; Mohd N Norhayati; Sharifah Halimah Jaafar
Journal:  Cochrane Database Syst Rev       Date:  2022-08-26

2.  Ten Years of Experience in Contraception Options for Teenagers in a Family Planning Center in Thrace and Review of the Literature.

Authors:  Panagiotis Tsikouras; Dorelia Deuteraiou; Anastasia Bothou; Xanthi Anthoulaki; Anna Chalkidou; Eleftherios Chatzimichael; Fotini Gaitatzi; Bachar Manav; Zacharoula Koukoul; Stefanos Zervoudis; Grigorios Trypsianis; George Galazios
Journal:  Int J Environ Res Public Health       Date:  2018-02-15       Impact factor: 3.390

3.  Adolescent Sexual Activity, Contraceptive Use, and Pregnancy in Britain and the U.S.: A Multidecade Comparison.

Authors:  Rachel H Scott; Kaye Wellings; Laura Lindberg
Journal:  J Adolesc Health       Date:  2020-02-03       Impact factor: 5.012

4.  Use of naproxen versus intracervical block for pain control during the 52-mg levonorgestrel-releasing intrauterine system insertion in young women: a multivariate analysis of a randomized controlled trial.

Authors:  Elaine Cristina Fontes de Oliveira; Thaís Baêta; Ana Paula Caldeira Brant; Agnaldo Silva-Filho; Ana Luiza Lunardi Rocha
Journal:  BMC Womens Health       Date:  2021-10-29       Impact factor: 2.809

5.  [Contraception in the German-language Wikipedia: a content and quality analysis].

Authors:  Nicola Döring; Stephan Lehmann; Claudia Schumann-Doermer
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2022-04-26       Impact factor: 1.595

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.